Back to 
NewEdge Advisors, LLC
NewEdge Advisors, LLC
PTGX
Showing 0 of 2 quarters
Position history for NewEdge Advisors, LLC's holdings in Protagonist Therapeutics, Inc.
No. NewEdge Advisors exited its PTGX position in Q3 2023. Its Q2 2023 13F listed 3,230 shares worth $89,214. NewEdge Advisors first reported PTGX in Q2 2023 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.